Lombard Odier Asset Management (Switzerland)’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-100,000
Closed -$3.75M 369
2018
Q2
$3.75M Hold
100,000
0.39% 60
2018
Q1
$3.93M Buy
+100,000
New +$3.65M 0.41% 49

Other funds holding XENT

Lombard Odier Asset Management (Switzerland)'s XENT Position: Q3 2018 in Review

Lombard Odier Asset Management (Switzerland) sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 100,000 shares — an estimated $3.75M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in XENT in Q1 2018 and held it in 2 quarters. The position peaked at $3.93M in Q1 2018. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 100,000 Intersect ENT, Inc shares in Q3 2018, an estimated $3.75M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 2 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Intersect ENT, Inc position peaked at $3.93M in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q3 2018, filed 14 Nov 2018.